nivolumab,ipilimumab
bms
['niche-2']
great presentation by in the presidential symposium ii at #esmo22 amazing results from the niche-2 trial on the use of #neoadjuvant #immunotherapy in locally advanced dmmr #coloncancer 
??????? ???? MD & Internal Medicine @emcs_tecdemty Fellow in Medical Oncology @incmnszmx